Deconex IR 385 mg/1
Guaifenesin and Phenylephrine HCl · TABLET · Poly Pharmaceuticals, Inc.
Deconex IR is a tablet containing guaifenesin and phenylephrine hcl at 385 mg/1, taken oral. Manufactured by Poly Pharmaceuticals, Inc..
Key Facts
- Brand Name
- Deconex IR
- Generic Name
- Guaifenesin and Phenylephrine HCl
- NDC Code (Product)
50991-736- Manufacturer
- Poly Pharmaceuticals, Inc.
- Strength
- 385 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- M012
- Drug Class
- Expectorant [EPC]
- Marketing Start
- 08/08/2016
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Full Prescribing Information
Indications & Usage
Uses Temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other respiratory allergies: helps loosen phlegm and thin bronchial secretions to make coughs more productive nasal congestion runny nose sneezing itching of the nose or throat itchy, watery eyes
Dosage & Administration
Directions: Adults and children 12 years of age and older: 1 tablet every 4 hours, not to exceed 6 tablets in 24 hours. Children age 6 to 12 years of age: 1/2 tablet every 4 hours, not to exceed 3 tablets in 24 hours or as directed by a doctor. Children 6 years of age and younger: Consult a physician.
Warnings
Warnings Do not exceed recommended dosage. A persistent cough may be a sign of a serious condition. If cough persists for more than 1 week, tends to recur, or is accompanied by fever, rash, or persistent headache, consult a doctor. Ask a doctor before use if you have a persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema, or if cough is accompanied by excessive phlegm heart disease high blood pressure thyroid disease diabetes difficulty in urination due to enlargement of the prostate gland Ask a doctor before use if you are taking sedatives or tranquilizers. Stop use and ask a doctor if nervousness, dizziness or sleeplessness occur Ask a doctor or pharmacist before use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. If pregnant or breast feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact…
Frequently Asked Questions
What is Deconex IR used for?
Deconex IR contains Guaifenesin and Phenylephrine HCl. It is a tablet taken oral. Consult your doctor for specific uses.
Is Deconex IR a controlled substance?
Deconex IR is not classified as a controlled substance by the DEA.
What is the generic name for Deconex IR?
The generic name for Deconex IR is Guaifenesin and Phenylephrine HCl. There are 1 other brand versions of Guaifenesin and Phenylephrine HCl.
What is the NDC code for Deconex IR 385 mg/1?
The NDC (National Drug Code) for Deconex IR 385 mg/1 is 50991-736, listed by Poly Pharmaceuticals, Inc..